Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Beam Therapeutics Inc. | beam-10k_20201231.htm |
| EX-32.2 - EX-32.2 - Beam Therapeutics Inc. | beam-ex322_8.htm |
| EX-31.2 - EX-31.2 - Beam Therapeutics Inc. | beam-ex312_6.htm |
| EX-31.1 - EX-31.1 - Beam Therapeutics Inc. | beam-ex311_7.htm |
| EX-23.1 - EX-23.1 - Beam Therapeutics Inc. | beam-ex231_9.htm |
| EX-21.1 - EX-21.1 - Beam Therapeutics Inc. | beam-ex211_12.htm |
| EX-10.29 - EX-10.29 - Beam Therapeutics Inc. | beam-ex1029_409.htm |
| EX-10.26 - EX-10.26 - Beam Therapeutics Inc. | beam-ex1026_406.htm |
| EX-10.25 - EX-10.25 - Beam Therapeutics Inc. | beam-ex1025_407.htm |
| EX-10.11 - EX-10.11 - Beam Therapeutics Inc. | beam-ex1011_159.htm |
| EX-10.10 - EX-10.10 - Beam Therapeutics Inc. | beam-ex1010_868.htm |
| EX-10.8 - EX-10.8 - Beam Therapeutics Inc. | beam-ex108_867.htm |
| EX-10.6 - EX-10.6 - Beam Therapeutics Inc. | beam-ex106_866.htm |
| EX-10.5 - EX-10.5 - Beam Therapeutics Inc. | beam-ex105_865.htm |
| EX-2.1 - EX-2.1 - Beam Therapeutics Inc. | beam-ex21_408.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Annual Report of Beam Therapeutics Inc (the “Company”) on Form 10-K for the period ending December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
By: |
|
/s/ John Evans |
|
|
|
|
|
John Evans |
|
|
|
|
Chief Executive Officer |
|
|
|
|
(Principal executive officer) |